» Articles » PMID: 15992633

The Effects of Plasma Insulin and Glucose on Myocardial Blood Flow in Patients with Type 1 Diabetes Mellitus

Overview
Date 2005 Jul 5
PMID 15992633
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The objective of this study was to determine the impact of insulin and glucose on myocardial vasodilator function in patients with type 1 diabetes mellitus (T1DM).

Background: The relative importance of plasma insulin and glucose levels on the abnormal vasodilator function observed in T1DM is unknown.

Methods: Twenty T1DM patients underwent positron emission tomography studies to measure myocardial blood flow (MBF) (in ml/g/min) at rest (MBFr) and during adenosine (MBFa), both under baseline metabolic conditions and then during either hyperinsulinemic-euglycemic clamp (HE) (n = 10; 40 +/- 9 years, 8 female subjects, hemoglobin A1c [HbA1c] 7.8 +/- 1.1%) or hyperinsulinemic-hyperglycemic clamp (HH) (n = 10; 44 +/- 12 years, 8 female subjects, hemoglobin A1c 7.7 +/- 0.6%).

Results: Both groups showed similar MBFr and MBFa under baseline metabolic conditions (p = NS). Compared with baseline conditions, MBFr increased in the HH group (p < 0.005), whereas it did not change in the HE group. Compared with baseline conditions, MBFa decreased in the HH group (p < 0.05) but did not change in the HE group. Myocardial perfusion reserve (MPR) (MBFa/MBFr) was similar between the HE and HH groups at baseline (p = NS). During clamp, MPR tended to decrease in the HH group (p < 0.1) but did not change in the HE group (p = NS) when compared with baseline conditions. However, during the clamp MPR was significantly lower in the HH group when compared with the HE group (p < 0.0001).

Conclusions: In the short term, hyperglycemia has a deleterious effect on myocardial vasodilator function, which outweighs the beneficial effect of hyperinsulinemia.

Citing Articles

Hyperinsulinemic Normoglycemia during Cardiac Surgery Reduces a Composite of 30-day Mortality and Serious In-hospital Complications: A Randomized Clinical Trial.

Duncan A, Sessler D, Sato H, Sato T, Nakazawa K, Carvalho G Anesthesiology. 2018; 128(6):1125-1139.

PMID: 29537981 PMC: 6509049. DOI: 10.1097/ALN.0000000000002156.


Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus.

McCormick L, Heck P, Ring L, Kydd A, Clarke S, Hoole S Cardiovasc Diabetol. 2015; 14:102.

PMID: 26253538 PMC: 4528379. DOI: 10.1186/s12933-015-0259-3.


Insulin resistance protects the heart from fuel overload in dysregulated metabolic states.

Taegtmeyer H, Beauloye C, Harmancey R, Hue L Am J Physiol Heart Circ Physiol. 2013; 305(12):H1693-7.

PMID: 24097426 PMC: 3882545. DOI: 10.1152/ajpheart.00854.2012.


Diastolic dysfunction and heart failure with a preserved ejection fraction: Relevance in critical illness and anaesthesia.

Maharaj R J Saudi Heart Assoc. 2013; 24(2):99-121.

PMID: 23960679 PMC: 3727489. DOI: 10.1016/j.jsha.2012.01.004.


Cerebral blood flow and glucose metabolism measured with positron emission tomography are decreased in human type 1 diabetes.

van Golen L, Huisman M, IJzerman R, Hoetjes N, Schwarte L, Lammertsma A Diabetes. 2013; 62(8):2898-904.

PMID: 23530004 PMC: 3717848. DOI: 10.2337/db12-1159.